What: we're asking for feedback on our draft inclusion and diversity guidance
Who: commercial and non-commercial sponsors, researchers and healthcare professionals
When: complete the survey by Monday 9 December 2024
Your chance to feedback on our inclusion and diversity guidance
We’ve launched an informal consultation on draft inclusion and diversity guidance we’re producing with the Medicines and Healthcare products Regulatory Agency (MHRA).
The guidance will help ensure research is designed to include people who could be impacted by the findings, and that people underserved by research are not overlooked.
We hope that this will help increase the diversity of people taking part in clinical trials and clinical investigations.
This is part of our wider work with the MHRA to update the UK’s clinical trials regulations.
We have developed a set of questions and supporting guidance for researchers to consider when they design clinical trials and clinical investigations. The answers to these questions will form the basis of an Inclusion and Diversity Plan.
Researchers can submit this plan as part of their application to Research Ethics Committees (RECs), who will use the information in the plan as part of their overall review of the application.
The questions and supporting guidance were developed alongside researchers, sponsors, REC members and public contributors.
We want to hear from you!
We’d be hugely grateful if you could spare 20 minutes to complete our short online survey by clicking the button below. All feedback is completely anonymous.
The survey closes on Monday 9 December 2024.
Thank you for your time and contribution.
Any information you provide will be collected, stored and used under the terms detailed in our Privacy Notice.
|